Lecanemab: Fc-Driven Microglial Plaque Clearance vs. Modest Clinical Gain and ARIA Risk
Lecanemab’s main action depends on its Fc fragment calling microglia into action: recent work from VIB and KU Leuven shows…
Lecanemab’s main action depends on its Fc fragment calling microglia into action: recent work from VIB and KU Leuven shows…